Clinical Trial Update: A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating venetoclax with azacitidine or decitabine in outpatient AML patients ineligible for intensive chemotherapy has completed; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Decitabine (Decitabine)
• Venetoclax (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Acute Myeloid Leukemia (AML), Cancer | Phase 3 | Status: COMPLETED | Results posted: 2023-03-20